Literature DB >> 9678127

Attitudes to current oral contraceptive use and future developments: the women's perspective.

N Fuchs1, H Prinz, U Koch.   

Abstract

OBJECTIVES: The study was planned to determine current trends in contraceptive usage and to examine the attitudes, needs and preferences of women with respect to oral contraceptives.
METHODS: Semi-structured interviews were carried out with women (n = 1201, aged 16-45 years) in Germany, the UK and France.
RESULTS: The study revealed that oral contraceptives were the most popular method of contraception employed, followed by condoms, and that the majority of respondents were aged 16-19 years when they first used an oral contraceptive. An important finding of the study was that an oral contraceptive was first used only after having sexual intercourse for the first time (within 1 year), emphasizing the importance of effective contraceptive information and education for adolescents. Regarding non-contraceptive health benefits, protection from ovarian and endometrial cancer was perceived by respondents to be of the greatest importance; however, few women were spontaneously aware of this benefit. When given a number of different oral contraceptive intake options to assess, the established 'once daily for 21 consecutive days' option remained the most popular, although a 'once weekly' alternative was cited by many women. When asked about the preferred frequency of menstrual bleeding, there was a polarization between women favoring the normal monthly bleed and those wanting a 'no-bleed' regimen.
CONCLUSION: Women are poorly informed about oral contraceptive use, and are largely unaware of the important long-term non-contraceptive benefits. Many women would prefer alternative pill intake options and a significant number would favor a 'no-bleed' regimen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9678127     DOI: 10.3109/13625189609150670

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  5 in total

1.  User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.

Authors:  Mary Short
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

2.  Patterns of contraceptive use in 5 European countries. European Study Group on Infertility and Subfecundity.

Authors:  A Spinelli; I F Talamanca; L Lauria
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

3.  Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.

Authors:  Abbey B Berenson; Susan D Odom; Carmen Radecki Breitkopf; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2008-07-03       Impact factor: 8.661

Review 4.  Added benefits and user satisfaction with a low-dose oral contraceptive containing drospirenone: results of three multicentre trials.

Authors:  Johannes Bitzer; Anna M Paoletti
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 3.580

5.  Current knowledge, attitude, and patterns of oral contraceptives utilization among women in Jordan.

Authors:  Sanaa K Bardaweel; Amal A Akour; Maria-Vanessa Z Kilani
Journal:  BMC Womens Health       Date:  2015-12-14       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.